Development and validation of a comprehensive acne severity scale

Journal of Cutaneous Medicine and Surgery

Volumn 11, Issue 6, 2007, Pages 211-216

  Tan, Jerry K L ^a   Tang, Jing ^a   Fung, Karen ^a   Gupta, Aditya K ^a   Thomas, D Richard ^a   Sapra, Sheetal ^a   Lynde, Charles ^a   Poulin, Yves ^a   Gulliver, Wayne ^a   Sehaldt, Rolf J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; ARTICLE; BACK; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FACE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; THORAX; VALIDATION STUDY;

ACNE VULGARIS; BACK; CANADA; FACE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THORAX; TREATMENT OUTCOME;

EID: 37549042370     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2007.00037     Document Type: Article

References (12)

1. Lehmann HP, Robinson KA, Andrews JS, et al. Acne therapy: a methodologic review. J Am Acad Dermatol 2002;47:231-40.
2. Stathakis V, Kilkenny M, Marks R. Descriptive epidemiology of acne vulgaris in the community. Australas J Dermatol 1997;38: 115-23.
3. O'Brien SC, Lewis JB, Cunliffe WJ. The Leeds revised acne grading system. J Dermatolog Treat 1998;9:215-20.
4. Doshi A, Zaheer A, Stiller M. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol 1997;36:416-8.
5. Allen BS, Smith G Jr. Various parameters for grading acne vulgaris. Arch Dermatol 1982;118:23-5.
6. US Department of Health and Human Services, Food and Drug Administration (November 2002). Dermatologic and Ophthalmic Drugs Advisory Committee Briefing. Available at: http://www.fda. gov/ohrms/dockets/ac/02/briefing/ 3904B1_02_Executive%20Summary. htm (accessed July 1, 2004).
7. Witkowski JA, Parish LC. The assessment of acne: an evaluation of grading and lesion counting in the measurement of acne. Clin Dermatol 2004;22:394-7.
8. Pochi PE, Shalita AR, Strauss JS, Webster SB. Report of the consensus conference on acne classification. J Am Acad Dermatol 1991;24:495-500.
9. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry; acne vulgaris: developing drugs for treatment; September 2005; 1-14. Available at: http://www.fda. gov/Cder/guidance/6499dft.htm (accessed February 12, 2005).
10. Lucky AW, Barber BL, Girman CJ, et al. A multirater validation study to assess the reliability of acne lesion counting. J Am Acad Dermatol 1996;35:559-65.
11. Tan JK, Fung K, Bulger L. Reliability of dermatologists in acne lesion counts and global assessments. J Cutan Med Surg 2006;10: 160-5.
12. Tan J, Fung KY, Khan S. Condensation and validation of a 4-item index of the Acne-QoL. Qual Life Res 2006;15:1203-10.